fda shortage semaglutide injection products resolved feb 21 2025 π’ has determined the of products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the Hims & Hers stock falls
Pay in 4 interest-free payments of $5.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5




















![GLP-1R-controlled signaling (Source: Smith et al. [45])](https://www.researchgate.net/publication/381173272/figure/fig3/AS:11431281420788153@1746267070985/GLP-1R-controlled-signaling-Source-Smith-et-al-45_Q320.jpg)





